(Q36928826)

17 August 2017

1 reference

title

The steroid hormone antagonist RU486. Mechanism at the cellular level and clinical applications (English)

1 reference

17 August 2017

The Steroid Hormone Antagonist RU486: Mechanism at the Cellular Level and Clinical Applications (English)

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

21 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

sex organ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

genitourinary system

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

corpus luteum

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

adrenal cortex hormone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

developed country

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

Western Europe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

female reproductive system

21 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

progestins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

hormone antagonist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

Mediterranean Countries

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

21 November 2022

author name string

E. E. Baulieu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778181

21 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1778181

21 November 2022

publication date

1 December 1991

1 reference

full work available at URL

17 August 2017

https://api.elsevier.com/content/article/PII:S0889852918302482?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

https://api.elsevier.com/content/article/PII:S0889852918302482?httpAccept=text/plain

21 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Endocrinology and Metabolism Clinics of North America

21 November 2022

published in

1 reference

17 August 2017

volume

20

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

873-891

1 reference

Steroid hormone antagonists at the receptor level: a role for the heat-shock protein MW 90,000 (hsp 90).

17 August 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond

21 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor

21 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Gene regulation by steroid hormones

21 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone

21 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Prostaglandins in fertility control

21 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in Man

21 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Monohydroxytamoxifen: An antioestrogen with high affinity for the chick oviduct oestrogen receptor

21 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

The cDNA-derived amino acid sequence of chick heat shock protein Mr 90,000 (HSP 90) reveals a "DNA like" structure: potential site of interaction with steroid receptors.

21 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486

21 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.

21 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-Delta;2-PGE, methyl ester) or the antiprogestogen RU 486

21 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Glucocorticoids locally disrupt an array of positioned nucleosomes on the rat tyrosine aminotransferase promoter in hepatoma cells

21 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Interaction of the chicken progesterone receptor with heat shock protein (HSP) 90

21 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist?

21 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Sequence and expression of a functional chicken progesterone receptor.

21 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone)

21 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation

21 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

The critical control of progesterone levels and pregnancy by antiprogesterone

21 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Contragestion with late luteal administration of RU 486 (Mifepristone)

21 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

The steroid and thyroid hormone receptor superfamily

21 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day

21 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

A protein kinase copurified with chick oviduct progesterone receptor

21 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle

21 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Progesterone receptor in the chick oviduct: an immunohistochemical study with antibodies to distinct receptor components

21 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Compared intracellular localization of the glucocorticosteroid and progesterone receptors: an immunocytochemical study

21 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Nuclear localization of two steroid receptor-associated proteins, hsp90 and p59

21 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Heteromeric nature of glucocorticoid receptors

21 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women

21 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Nuclear receptors enhance our understanding of transcription regulation

21 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Chick oviduct glucocorticosteroid receptor. Specific binding of the synthetic steroid RU 486 and immunological studies with antibodies to chick oviduct progesterone receptor

21 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro

21 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers

21 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Biochemistry, molecular biology, and physiology of the glucocorticoid receptor

21 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Regulation of gene expression by nuclear hormone receptors

21 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effects

21 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Mechanism of Action of the Female Sex Hormones

21 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Common non-hormone binding component in non-transformed chick oviduct receptors of four steroid hormones

21 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Nonsteroidal antiestrogens: Their biological effects and potential mechanisms of action

21 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells

21 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer

21 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Late postcoital treatment against pregnancy with antiprogesterone RU 486

21 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Induction of midcycle gonadotropin surge by ovarian steroids in women: a critical evaluation

21 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Characterization of a casein kinase which interacts with the rabbit progesterone receptor. Differences with the in vivo hormone-dependent phosphorylation

21 November 2022

65

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Glucocorticoid receptors lacking hormone-binding activity are bound in nuclei of ATP-depleted cells

21 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Steroid hormone receptors compete for factors that mediate their enhancer function

21 November 2022

68

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA

21 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

RU 38486: potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation

21 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Effects of RU486 on progesterone secretion by human preovulatory granulosa cells in culture

21 November 2022

74

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor.

21 November 2022

78

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Signal transduction by steroid hormones: nuclear localization is differentially regulated in estrogen and glucocorticoid receptors

21 November 2022

79

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Glucocorticoid receptors bound to the antagonist RU486 are not downregulated despite their capacity to interact in vitro with defined gene regions

21 November 2022

81

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Involvement of a non-hormone-binding 90-kilodalton protein in the nontransformed 8S form of the rabbit uterus progesterone receptor

21 November 2022

84

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Absence of correlation between antiestrogenic activity and binding affinity for the estrogen receptor

21 November 2022

87

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary

21 November 2022

88

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women

21 November 2022

92

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience

21 November 2022

95

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium

21 November 2022

97

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

A 59-kilodalton protein associated with progestin, estrogen, androgen, and glucocorticoid receptors.

21 November 2022

98

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Uses of RU 486 for contragestion: an update

21 November 2022

100

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Antiprogestational steroids: a new dimension in human fertility regulation

21 November 2022

101

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Receptors for glucocorticosteroid and progesterone recognize distinct features of a DNA regulatory element

21 November 2022

102

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Progesterone antagonist (RU 486) for cervical dilation, labor induction, and delivery in monkeys: effectiveness in combination with oxytocin

21 November 2022

103

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Nuclear localization of unoccupied oestrogen receptors

21 November 2022

105

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

Augmentation of progesterone receptor concentration by progesterone and estrogen treatments in the chick oviduct

21 November 2022

106

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30248-2

21 November 2022

Identifiers

1 reference